Understanding how proteins are degraded without ubiquitin
Characterization of a ubiquitin-independent pathway for proteasomal degradation
This study is looking at a new way that cells break down proteins without using a common signal, which could help us understand how protein regulation works and its impact on diseases like Alzheimer's.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10890115 on NIH RePORTER |
What this research studies
This research investigates a newly discovered pathway for protein degradation that does not rely on ubiquitin, a common signal for protein breakdown. By using enhanced green fluorescent protein (EGFP) fused with various peptides, the researchers aim to explore how these proteins are recognized and processed by the proteasome, the cell's main protein-degrading complex. The study will involve genetic and biochemical methods to identify the mechanisms and substrates involved in this ubiquitin-independent pathway. This could enhance our understanding of protein regulation and its implications for diseases like Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Alzheimer's disease or related neurodegenerative conditions.
Not a fit: Patients with conditions unrelated to protein degradation or those not affected by neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into protein degradation mechanisms, potentially informing treatments for conditions like Alzheimer's disease.
How similar studies have performed: While the ubiquitin-independent pathway is a relatively novel area of investigation, previous studies have shown promise in understanding alternative protein degradation mechanisms.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Mena, Elijah L — Brigham and Women's Hospital
- Study coordinator: Mena, Elijah L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.